https://www.marketscreener.com/quote/stock/KITE-PHARMA-INC-16738480/news/Kite-Pharma-Highlights-Durable-Complete-Remissions-Up-to-56-Months-in-Patients-with-Chemorefracto-24788366/?utm_source=telegram&utm_medium=social&utm_campaign=share